51MEDIUM

MVP

MEDICALDEV FPO [MVP]
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analgesia during short procedures. The company also distributes asthma and chronic obstructive pulmonary disease products, such space chambers, peak flow meters, portable nebulisers, and silicon face mask. Medical Developments International Limited was founded in 1972 and is headquartered in Scoresby, Australia.
Healthcare · ASX Small Cap
$0.3950 +2.6%

Updated 26 Mar 2026 · Scores refresh every scan

Score Breakdown

Technical72
Catalyst50
Sentiment50
Fundamental88
Momentum41
Risk Gate50
Get alerts when MVP's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Track MVP — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • MACD just crossed bullish — momentum is shifting to the upside
  • Volume surging at 2.1x normal while price climbs — real buying conviction behind this move
  • Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
  • Cash positive / operating cashflow positive
  • 4C filed 2026-01-29
  • Low P/S ratio (1.1x)
  • Moderate revenue growth (+8%)
  • Near 52-week low (4% of range)
  • Small-cap ($20-100M)
  • CANSLIM A: Turned profitable
  • CANSLIM I: Institutional ownership (25%)
  • Sentiment is mixed — no strong consensus either way
  • RBA hiking (-3pts)

Risk Signals

  • Below the 200-day average — the long-term trend is still working against it
  • Negative profit margins (-1%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Long-term momentum is negative — down 32% over the past year
  • The bigger volume days are the down days — volume-weighted momentum is negative (-0.92%/day)
  • Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about MVP
"What's driving MVP's score?" "How does MVP compare to peers?" "Key risks for MVP?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE FY26 Half Year Announcement
NONE FY26 Half Year Presentation
NONE FY26 Half Year Report (including Appendix 4D)
LOW Appendix 4C and Quarterly Activity Report 31 December 2025

Recent ASX Announcements

2026-02-18 FY26 Half Year Announcement PRICE SENSITIVE
2026-02-18 FY26 Half Year Presentation PRICE SENSITIVE
2026-02-18 FY26 Half Year Report (including Appendix 4D) PRICE SENSITIVE
2026-02-16 FY26 Half Year Announcement Details
2026-01-29 Appendix 4C and Quarterly Activity Report 31 December 2025 PRICE SENSITIVE

Key Metrics

$44.5M
Market Cap
102K
Avg Volume
2.1x
Vol Ratio
$0.38 — $0.77
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-0.8%
ROE
-1.1%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsimprovingCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 68%
LLeader vs LaggardlaggardRS: -6
IInstitutional SponsorshippassInst: 25%
MMarket DirectionneutralNeutral

Sector: Healthcare

Ranked #28 of 117 · Sector avg: 46

View all Healthcare signals →
Related Tickers
ATX 59PNV 56IMM 55EYE 55AHC 55
Compare:MVP vs ATXMVP vs PNVMVP vs IMM
Scout Pro — Deeper Analysis for MVP
Try Pro free for 30 days
Share this analysis

Track MVP and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required